SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE RISING ORAL DOSES OF BI 1021958, A NOVEL CRTH2 ANTAGONIST, IN HEALTHY MALE VOLUNTEERS.

被引：0
|
作者：
Koenen, R. [1 ]
Fowler, A. [2 ]
Gupta, A. [1 ]
Hilbert, J. [3 ]
机构：
[1] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
[2] Boehringer Ingelheim Ltd, Bracknell, Berks, England
[3] Boehringer Ingelheim Pharmaceut Inc, 90 E Ridge POB 368, Ridgefield, CT 06877 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2016年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-011
引用
收藏
页码：S78 / S78
页数：1
相关论文
共 50 条
  • [31] Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses
    Rolan, Paul
    Gibbons, Jacqueline A.
    He, Lin
    Chang, Eppie
    Jones, Drew
    Gross, Matthew I.
    Davidson, Jennifer Bahr
    Sanftner, Laura M.
    Johnson, Kirk W.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (06) : 792 - 801
  • [32] Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of Vixotrigine in Healthy Volunteers
    Naik, Himanshu
    Steiner, Deb J.
    Versavel, Mark
    Palmer, Joanne
    Fong, Regan
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (04): : 1272 - 1279
  • [33] Safety, tolerability, pharmacokinetics and pharmacodynamics of irbesartan after single and multiple doses in healthy male subjects.
    Marino, MR
    Langenbacher, KM
    Ford, NF
    Uderman, HD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PII53 - PII53
  • [34] Safety, Tolerability, and Pharmacokinetics of Single Rising Doses of Bi 1569912 in Healthy Males: A Phase I Study
    Desch, Michael
    Huennemeyer, Andreas
    Suessmuth, Sigurd D.
    BIOLOGICAL PSYCHIATRY, 2022, 91 (09) : S379 - S379
  • [35] The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of RO5068760, an MEK Inhibitor, in Healthy Volunteers: Assessment of Target Suppression
    Lee, Lucy
    Niu, Huifeng
    Goelzer, Petra
    Rueger, Ruediger
    Deutsch, Jonathan
    Busse-Reid, Rachel
    DeSchepper, Stefanie
    Blotner, Steve
    Barrett, Joanne
    Weissgerber, Georges
    Peck, Richard
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (12): : 1397 - 1405
  • [36] PHARMACOKINETICS, PHARMACODYNAMICS, AND TOLERABILITY OF CKD-712 AFTER A SINGLE INTRAVENOUS ADMINISTRATION IN HEALTHY VOLUNTEERS.
    Park, S.
    Lee, S.
    Moon, S.
    Park, K.
    Chung, J.
    Jang, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S46 - S46
  • [37] SAFETY AND PHARMACOKINETICS OF ESCALATING SINGLE DOSES OF INJECTABLE CEFETAMET SODIUM IN HEALTHY VOLUNTEERS.
    Miao, J.
    Sun, J.
    Qin, Y.
    Wang, Y.
    Liang, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S56 - S56
  • [38] Pharmacokinetics, Pharmacodynamics, Tolerability and Safety of Single Doses of Bivalirudin in Healthy Chinese Subjects
    Zhang, Dongmei
    Wang, Zining
    Zhao, Xia
    Lu, Wei
    Gu, Jingkai
    Cui, Yimin
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2011, 34 (12) : 1841 - 1848
  • [39] Phase 1 studies of the safety, tolerability, pharmacokinetics, and pharmacodynamics of BI 690517 (vicadrostat), a novel aldosterone synthase inhibitor, in healthy male volunteers
    Schulze, Friedrich
    Schaible, Jennifer
    Goettel, Markus
    Tanaka, Yuko
    Hohl, Kathrin
    Schultz, Armin
    Jang, In-Jin
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025,
  • [40] Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo-Controlled Studies in Healthy Volunteers
    Erpenbeck, Veit J.
    Vets, Eva
    Gheyle, Lien
    Osuntokun, Wande
    Larbig, Michael
    Neelakantham, Srikanth
    Sandham, David
    Dubois, Gerald
    Elbast, Walid
    Goldsmith, Paul
    Weiss, Markus
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2016, 5 (04): : 306 - 313
12345